Inhibitors of the hedgehog pathway

The present invention is directed to a compound of Formula I or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RIDGWAY, BRIAN HUGH, BAHCECI, SULEY, BAJJALIEH, WILLIAM, WANG, YONG, TESFAI, ZEROM, HUYNH, TAI PHAT, FORSYTH, TIMOTHY PATRICK, CHEN, JEFF, MANN, GRACE, SHI, XIAN, MAC, MORRISON B, TAKEUCHI, CRAIG STACY, SANGALANG, JOAN C, MARLOWE, CHARLES K, EPSHTEYN, SERGEY, KIM, BYUNG GYU, LEAHY, JAMES W, LEE, MATTHEW SANGYUP, LEWIS, GARY L
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to a compound of Formula I or a single isomer thereof; where the compound is optionally as a pharmaceutically acceptable salt, hydrate, solvate or combination thereof, in addition to methods of preparing a Compound of Formula I, and methods of using a Compound of Formula I to treat cancer.